Connor Clark & Lunn Investment Management Ltd. Buys 50,870 Shares of Sotera Health (NASDAQ:SHC)

Connor Clark & Lunn Investment Management Ltd. lifted its stake in shares of Sotera Health (NASDAQ:SHC) by 128.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 90,332 shares of the company’s stock after purchasing an additional 50,870 shares during the quarter. Connor Clark & Lunn Investment Management Ltd.’s holdings in Sotera Health were worth $1,236,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the stock. Victory Capital Management Inc. increased its holdings in Sotera Health by 25.7% during the 3rd quarter. Victory Capital Management Inc. now owns 32,610 shares of the company’s stock worth $545,000 after acquiring an additional 6,666 shares during the period. Mutual of America Capital Management LLC increased its holdings in shares of Sotera Health by 15.9% in the third quarter. Mutual of America Capital Management LLC now owns 82,654 shares of the company’s stock worth $1,380,000 after purchasing an additional 11,342 shares during the period. Thrivent Financial for Lutherans raised its position in shares of Sotera Health by 19.4% in the third quarter. Thrivent Financial for Lutherans now owns 35,929 shares of the company’s stock worth $600,000 after buying an additional 5,835 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its stake in Sotera Health by 18.3% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,348,917 shares of the company’s stock valued at $22,527,000 after buying an additional 208,914 shares during the period. Finally, Sessa Capital IM L.P. grew its position in Sotera Health by 46.5% during the third quarter. Sessa Capital IM L.P. now owns 6,300,597 shares of the company’s stock worth $105,220,000 after buying an additional 2,000,000 shares in the last quarter. Hedge funds and other institutional investors own 91.03% of the company’s stock.

Sotera Health Stock Up 2.1 %

Shares of SHC opened at $12.24 on Thursday. The firm has a market cap of $3.47 billion, a P/E ratio of 48.96 and a beta of 1.92. Sotera Health has a 1 year low of $10.71 and a 1 year high of $17.08. The stock has a 50 day simple moving average of $12.99 and a two-hundred day simple moving average of $14.19. The company has a debt-to-equity ratio of 4.91, a current ratio of 2.88 and a quick ratio of 2.61.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on the company. Barclays lowered their price target on Sotera Health from $17.00 to $16.00 and set an “overweight” rating on the stock in a report on Friday, February 28th. Royal Bank of Canada reissued an “outperform” rating and issued a $17.00 price target on shares of Sotera Health in a research note on Thursday, November 21st. Finally, The Goldman Sachs Group began coverage on shares of Sotera Health in a research report on Friday, December 6th. They set a “neutral” rating and a $14.00 price objective on the stock. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $15.92.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.